Inventor
KIERSTEAD RICHARD W
31 patents
Patents
31 patentsUS4927838AMay 22, 1990
Pyridine compounds which are useful in treating a disease state characterized by an excess of platelet activating factors
HOFFMANN LA ROCHE101 citations93
US4788206ANov 29, 1988
Pentadieneamides
HOFFMANN LA ROCHE32 citations92
US4786646ANov 22, 1988
Cyclopropylpropenamides
HOFFMANN LA ROCHE42 citations92
US4559403ADec 17, 1985
Substituted isoquinolines
HOFFMANN LA ROCHE34 citations91
US4169154ASep 25, 1979
Method of treating depression with thiourea derivatives
HOFFMANN LA ROCHE43 citations91
US5344843ASep 6, 1994
Cat-1 inhibitors, pharmaceutical compositions and methods of use
HOFFMANN LA ROCHE28 citations88
US4304721ADec 8, 1981
Adrenergic blocking agents
HOFFMANN LA ROCHE25 citations81
US4632925ADec 30, 1986
N-substituted diphenylpiperidines and antiobesity use thereof
HOFFMANN LA ROCHE23 citations80
US4348396ASep 7, 1982
Substituted 11-oxo-11H-pyrido[2,1-b]quinazolines and method of inhibiting allergic reactions with them
HOFFMANN LA ROCHE8 citations74
US4927826AMay 22, 1990
Cycloproylpropenamides useful as platelet activing factor (PAF) antagonists
HOFFMANN LA ROCHE10 citations73
US4329289AMay 11, 1982
Adrenergic blocking agents
HOFFMANN LA ROCHE10 citations73
US4285873AAug 25, 1981
Adrenergic blocking agents
HOFFMANN LA ROCHE9 citations73
US4278608AJul 14, 1981
Adrenergic blocking agents
HOFFMANN LA ROCHE9 citations73
US4247710AJan 27, 1981
Intermediate in the production of adrenergic blocking agents
HOFFMANN LA ROCHE12 citations73
US4202978AMay 13, 1980
(S)-1-[2-(4-(2-Hydroxy-s-(1-alkylaminopropoxy)phenylalkyl]-4-phenylpiperazines
HOFFMANN LA ROCHE18 citations73
US4443619AApr 17, 1984
Chlorocitric acids
HOFFMANN LA ROCHE8 citations72
US4152424AMay 1, 1979
Antibiotic 1745A/X and methods for the production thereof
HOFFMANN LA ROCHE8 citations72
US4471116ASep 11, 1984
Substituted (10H-phenothiazin-10-L)-propyl-1-piperazines
HOFFMANN LA ROCHE14 citations68
US4975438ADec 4, 1990
Pentadieneamide compounds which have useful activity of treating a disease characterized by an excess of platelet activating factor
HOFFMANN LA ROCHE3 citations62
US4595689AJun 17, 1986
4-(8-bromodibenz[b,f]oxepin-10-yl)-1,2,3,6-tetrahydro-1-methylpyridine and 4-(2-bromodibenzo[a,d]cyclophetatriene-11-yl)-1,2,3,6-tetrahydro-1-methylpyridine for dermal inflammation
HOFFMANN LA ROCHE2 citations62
US4336382AJun 22, 1982
1,4-Disubstituted piperazine compounds
HOFFMANN LA ROCHE4 citations62
US4544657AOct 1, 1985
Substituted isoquinolines
HOFFMANN LA ROCHE4 citations61
US4365070ADec 21, 1982
Chlorocitric acids
HOFFMANN LA ROCHE2 citations61
US4354039AOct 12, 1982
Chlorocitric acids
HOFFMANN LA ROCHE2 citations61
US4150138AApr 17, 1979
Method of reducing blood pressure with thiourea derivatives and guanidine derivatives
HOFFMANN LA ROCHE4 citations61
US4070376AJan 24, 1978
Antibiotic 1745A/X and methods for the production thereof
HOFFMANN LA ROCHE3 citations59
US4314085AFeb 2, 1982
Intermediates for preparing adrenergic blocking agents
HOFFMANN LA ROCHE1 citations51
US4301300ANov 17, 1981
Sulfonamide intermediates for adrenergic blocking agents
HOFFMANN LA ROCHE0 citations51
US4352758AOct 5, 1982
Chlorocitric acids
HOFFMANN LA ROCHE0 citations50
US4340754AJul 20, 1982
Process for making chlorocitric acid
HOFFMANN LA ROCHE0 citations50
US4312885AJan 26, 1982
Chlorocitric acids
HOFFMANN LA ROCHE0 citations50